Natco Pharma slips on receiving one observation from USFDA for Kothur formulation facility

09 Mar 2020 Evaluate

Natco Pharma is currently trading at Rs. 593.40, down by 7.45 points or 1.24% from its previous closing of Rs. 600.85 on the BSE.

The scrip opened at Rs. 600.00 and has touched a high and low of Rs. 615.00 and Rs. 585.95 respectively. So far 3017 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 737.80 on 10-Feb-2020 and a 52 week low of Rs. 482.00 on 28-May-2019.

Last one week high and low of the scrip stood at Rs. 632.70 and Rs. 572.40 respectively. The current market cap of the company is Rs. 10756.58 crore.

The promoters holding in the company stood at 48.98%, while Institutions and Non-Institutions held 31.62% and 19.40% respectively.

US Food and Drug Administration (USFDA) has completed Pre-Approval inspection at Natco Pharma’s formulation facility in Kothur Village, near Hyderabad, India, which was conducted from March 2, 2020 to March 6, 2020.

At the end of the inspection, the facility received a single observation related to equipment qualification of a co-mill used in the process that had operating speed slightly outside the qualification range. The company believes that this is a minor observation and can be addressed within a short period of time.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

 

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×